The proposed research will continue our work in the area of the regulation of lipid fuel metabolism. Lipid energy is transported in the blood in severa forms, including chylomicrons and free fatty acids (FFA). Chylomicrons are key elements in the absorption and storage of dietary fat, and also play a role in the pathogenesis of atherosclerosis via the production of remnant particles, but their role as a direct fuel source has not been extensively investigated. FFAs are the major lipid fuel in the body, and increases in their concentration have been shown to cause insulin resistance, endothelial dysfunction and increases in the production of very low density lipoproteins. FFAs are released into the blood through the action of hormone sensitive lipase on triglyceride stores in fat cells. Very little is known about the role of chylomicrons in FFA metabolism, but the potential contribution of chylomicrons to FFA is considerable, especially in people who consume high fat diets. Initial studies indicate that in addition to the role of chylomicrons in fat storage, a portion of chylomicron fatty acids are released as FFA in a process called "spillover". A study of spillover in the splanchnic bed found very high rates of splanchnic spillover in overweight and obese individuals with hypertriglyceridemia. Subsequent studies have shown that intravenous infusion of niacin, a drug known to suppress FFA release, produced a significant reduction in fractional spillover, whereas insulin infusion had no effect. Furthermore, in people with type 2 diabetes spillover correlated negatively with leg fat - that is, individuals with a large amount of leg fat ad lower spillover (an indication of more efficient fat storage), while those with small amounts of le fat had higher spillover, indicating less efficient storage. No information is available on spillovr in lower body fat tissue, nor on its relationship with spillover in the splanchnic bed (which includes visceral fat). Extremely accurate and precise methods have been developed by the investigator for the measurement of the concentration and specific activity of FFA and chylomicron triglyceride fatty acids in plasma. In addition, a tracer method for accurately determining the kinetics of chylomicrons has been developed. In the proposed studies, the tracer technique will be used to systematically investigate the contribution of chylomicrons to total FFA availability. The technique will be applied to lean and obese subjects, including people who have undergone gastric bypass surgery. Specifically, these studies will: 1) determine whether weight loss after gastric bypass reduces spillover from chylomicrons;2) determine whether acute lowering of FFA with niacin infusion reduces spillover in overweight and obese people;3) determine whether women with upper body obesity have greater systemic spillover than women with lower body obesity, and whether body fat distribution determines chylomicron triglyceride uptake and spillover in leg and splanchnic fat and 4) determine whether women with upper body obesity gain less weight during supervised overfeeding than women with lower body obesity.

Public Health Relevance

Elevated free fatty acids levels (FFAs) in blood are a recognized cause of insulin resistance and may contribute to the development of diabetes, high blood pressure and cardiovascular disease. Dietary fat may contribute to FFAs by a process known as spillover, which occurs during fat storage. This work is a comprehensive evaluation of the importance of spillover as a contributor to FFAs and as a marker for the efficiency of fat storage.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01HL067933-11
Application #
8704983
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Ershow, Abby
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Curry, Timothy B; Hines, Casey N; Barnes, Jill N et al. (2014) Relationship of muscle sympathetic nerve activity to insulin sensitivity. Clin Auton Res 24:77-85
Miles, John M; Rule, Andrew D; Borlaug, Barry A (2014) Use of metformin in diseases of aging. Curr Diab Rep 14:490
Nelson, Robert H; Mundi, Manpreet S; Vlazny, Danielle T et al. (2013) Kinetics of saturated, monounsaturated, and polyunsaturated fatty acids in humans. Diabetes 62:783-8
Curry, Timothy B; Somaraju, Madhuri; Hines, Casey N et al. (2013) Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery. Obesity (Silver Spring) 21:480-5
Almandoz, Jaime P; Singh, Ekta; Howell, Lisa A et al. (2013) Spillover of Fatty acids during dietary fat storage in type 2 diabetes: relationship to body fat depots and effects of weight loss. Diabetes 62:1897-903
Curry, Timothy B; Roberts, Shelly K; Basu, Rita et al. (2011) Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab 300:E746-51
Sparks, Lauren M; Ukropcova, Barbara; Smith, Jana et al. (2009) Relation of adipose tissue to metabolic flexibility. Diabetes Res Clin Pract 83:32-43
Sparks, Lauren M; Pasarica, Magdalena; Sereda, Olga et al. (2009) Effect of adipose tissue on the sexual dimorphism in metabolic flexibility. Metabolism 58:1564-71
Sheikh-Ali, Mae; Karon, Brad S; Basu, Ananda et al. (2008) Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care 31:643-7
Miles, J M; McMahon, M M; Isley, W L (2008) No, the glycaemic target in the critically ill should not be Diabetologia 51:916-20

Showing the most recent 10 out of 16 publications